Aurealis Therapeutics logo

Aurealis Therapeutics jobs and careers

Finland

As of October 24, 2026, Aurealis Therapeutics has no open roles listed.

About Aurealis Therapeutics

Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target cell and gene therapy platform, based on genetically modified safe lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers - deadly Cancers - Ovarian Cancer, Peritoneal Carcinomatosis - Inflammation. After successfully completing our Phase 1 clinical study in Diabetic Foot Ulcer (DFU) patients with our lead clinical product AUP-16, our DFU Phase 2 study is ongoing in Italy, Germany and Poland. Venous Ulcers and other ulcers will follow. In Oncology, we are building on impressive pre-clinical data with Oncolytic Bacteria lead candidate AUP-55, which shows increased survival in Ovarian Cancer and peritoneal carcinomatosis. Our pipeline also includes Inflammation, at discovery stage.

Employees
11 to 50
Headquarters
Finland

Leadership

The top of Aurealis Therapeutics's org chart, with how many people report into each leader.

JY

Juha Yrjänheikki

CEO

Jobs at Aurealis Therapeutics

No open positions right now. Explore more companies on TheJobsMap.

Aurealis Therapeutics jobs: common questions

Is Aurealis Therapeutics hiring right now?
Aurealis Therapeutics has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Aurealis Therapeutics's careers site.
Where is Aurealis Therapeutics headquartered?
Aurealis Therapeutics is headquartered in Finland.
Who leads Aurealis Therapeutics?
Juha Yrjänheikki, CEO, is at the top of Aurealis Therapeutics's org chart.
How do I apply for a job at Aurealis Therapeutics?
Pick a role on Aurealis Therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on Aurealis Therapeutics's own careers site, so you apply directly with the employer.